FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

The page contains only an error message (Error code: 0.a5643017.1773850139.292a8251) and no substantive financial content. There are no data, events, or company/market details to act on and no expected market impact.

Analysis

The page contains only an error message (Error code: 0.a5643017.1773850139.292a8251) and no substantive financial content. There are no data, events, or company/market details to act on and no expected market impact.